Lack of genotype–phenotype correlations and outcome in MCAD deficiency diagnosed by newborn screening in New York State
Georgianne L. Arnold(University of Rochester Medical Center), Michele Caggana(New York State Department of Health), Ellen DeVincentis(Women & Children's Hospital of Buffalo), Melissa Wasserstein(Icahn School of Medicine at Mount Sinai), Darius J. Adams, Patricia Galvin‐Parton(Stony Brook University), Shideh Mofidi(Maria Fareri Children's Hospital), Paul A. Levy, Joan E. Pellegrino(SUNY Upstate Medical University), David Kronn(New York Medical College), Matthew Nichols(New York State Department of Health), Richard W. Erbe(Women & Children's Hospital of Buffalo), Carlos A. Saavedra‐Matiz(New York State Department of Health)
Cited by 54
Related Papers
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia
|Cell Reports|2019|333
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease
|Genetics in Medicine|2009|292
Phenylketonuria Scientific Review Conference: State of the science and future research needs
|Molecular Genetics and Metabolism|2014|271
<i>GRIN2B</i> encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects
|Journal of Medical Genetics|2017|254
Schwannomatosis
|Neurology|1996|244